High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma

Overview of attention for article published in Bone Marrow Transplantation, June 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news: 1 news outlet

twitter: 30 X users

Citations

dimensions_citation: 23 Dimensions

Readers on

mendeley: 24 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Highdose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma

Bioportfolio, 12 Jun 2019

| NEJM Related Biotechnology, Pharmaceutical and Healthcare News Original Article: High-dose bendamustine and melphalan…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.